{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:35:09Z","timestamp":1777480509092,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jceh.2025.103124","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:42:57Z","timestamp":1754415777000},"page":"103124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patterns of Liver Injury and Adaptation in Patients With Abdominal Tuberculosis on Antituberculosis Treatment: A Prospective Cohort Study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8110-7966","authenticated-orcid":false,"given":"Abhishek","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5136-4865","authenticated-orcid":false,"given":"Ramesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-7784","authenticated-orcid":false,"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-1382","authenticated-orcid":false,"given":"Sudhir","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8209-8648","authenticated-orcid":false,"given":"Sudheer","family":"Marrapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-4129","authenticated-orcid":false,"given":"Utpal","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-8910","authenticated-orcid":false,"given":"Rajeev N.","family":"Priyadarshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.103124_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO's global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jceh.2025.103124_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12889-023-17495-6","article-title":"Global, regional and national trends in tuberculosis incidence and main risk factors: a study using data from 2000 to 2021","volume":"24","author":"Bai","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jceh.2025.103124_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12664-024-01643-w","article-title":"Incidence and risk factors of antituberculosis drug-induced liver injury in India: a systematic review and meta-analysis","volume":"44","author":"Kumar","year":"2025","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103124_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103124_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jceh.2020.11.002","article-title":"The Indian network of drug-induced liver injury: etiology, clinical features, outcome and prognostic markers in 1288 patients","volume":"11","author":"Devarbhavi","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103124_bib6","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/hep.23534","article-title":"Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome","volume":"51","author":"Kumar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103124_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103124_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/TROG_20113203_167","article-title":"Antituberculous drug-induced liver injury: current perspective","volume":"32","author":"Devarbhavi","year":"2011","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103124_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/trstmh\/traa144","article-title":"Standard versus sequential anti-tubercular treatment in patients with tuberculous meningitis: a randomized controlled trial","volume":"115","author":"Misra","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.jceh.2025.103124_bib10","first-page":"OG01","article-title":"Incidence and clinical profile of antituberculosis treatment-induced hepatitis in a tertiary care hospital in Southern India","volume":"14","author":"Juganya","year":"2020","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jceh.2025.103124_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00641-18","article-title":"Protein binding of first-line antituberculosis drugs","volume":"62","author":"Alghamdi","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jceh.2025.103124_bib12","first-page":"81","article-title":"Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity","volume":"132","author":"Singla","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jceh.2025.103124_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114400","article-title":"Gut microbiota affects sensitivity to immune-mediated isoniazid-induced liver injury","volume":"160","author":"Liu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jceh.2025.103124_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5114\/ceh.2019.83158","article-title":"Extra-abdominal involvement is associated with antitubercular therapy-related hepatitis in patients treated for abdominal tuberculosis","volume":"5","author":"Dawra","year":"2019","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103124_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4103\/ijmy.ijmy_195_21","article-title":"Abdominal tuberculosis: clinical profile and outcome","volume":"10","author":"Dhali","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.jceh.2025.103124_bib16","article-title":"Abdominal tuberculosis in Indians: still very pertinent","volume":"15","author":"Singh","year":"2019","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.jceh.2025.103124_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/liv.12988","article-title":"Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications","volume":"36","author":"Dara","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103124_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.14218\/JCTH.2021.00271","article-title":"Statin-induced liver injury patterns: a clinical review","volume":"10","author":"Averbukh","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2025.103124_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.9740\/mhc.2018.07.184","article-title":"Phenytoin-induced chronic liver enzyme elevation and hepatic fibrosis: a case report","volume":"8","author":"Curry","year":"2018","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.jceh.2025.103124_bib20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jceh.2025.103124_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1378\/chest.68.2.181","article-title":"Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy","volume":"68","author":"Mitchell","year":"1975","journal-title":"Chest"},{"key":"10.1016\/j.jceh.2025.103124_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/17425255.2025.2495955","article-title":"DILI prediction in drug development: present and future","volume":"21","author":"Uetrecht","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jceh.2025.103124_bib23","doi-asserted-by":"crossref","first-page":"14728","DOI":"10.1073\/pnas.0904489106","article-title":"Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism","volume":"106","author":"Clayton","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jceh.2025.103124_bib24","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i5.106618","article-title":"Acute liver failure from anti-tuberculosis drug-induced liver injury: an update","volume":"17","author":"Kumar","year":"2025","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2025.103124_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jinf.2016.10.009","article-title":"Evaluation of vitamin status in patients with pulmonary tuberculosis","volume":"74","author":"Oh","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.jceh.2025.103124_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/ijmy.ijmy_19_17","article-title":"Cholecalciferol for prophylaxis against antituberculosis therapy-induced liver disorders among naive patients with pulmonary tuberculosis: a randomized, comparative study","volume":"6","author":"Hasanain","year":"2017","journal-title":"Int J Mycobact"},{"key":"10.1016\/j.jceh.2025.103124_bib27","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1038\/s41598-023-34137-4","article-title":"Increased TG to HDL-C ratio is associated with severity of drug-induced liver injury","volume":"13","author":"Jia","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2025.103124_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1440-1681.2010.05380.x","article-title":"Anti-oxidant properties of high-density lipoprotein and atherosclerosis","volume":"37","author":"Podrez","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jceh.2025.103124_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0377-1237(06)80155-3","article-title":"Risk factors of hepatotoxicity during Anti- tuberculosis treatment","volume":"62","author":"Anand","year":"2006","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.jceh.2025.103124_bib30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1440-1746.2005.04048.x","article-title":"Monitoring and management of antituberculosis drug induced hepatotoxicity","volume":"20","author":"Agal","year":"2005","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:14:16Z","timestamp":1763399656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325006243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0973688325006243"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103124","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Liver Injury and Adaptation in Patients With Abdominal Tuberculosis on Antituberculosis Treatment: A Prospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103124"}}